Abstract
Although IGF-I was known to stimulate the growth of pancreatic islet cells from early in vitro experiments and in vivo reports on rodents, recent gene targeting experiments have indicated that IGF-I and its receptor do not play a major role in normal islet cell growth. In our previous reports, liver- or pancreatic-specific IGF-I deficiency caused no decrease in β-cell mass; a general and β-cell-enriched IGF-I overexpression caused no change in normal islet cell growth. On the other hand, increased metabolic demands (such as in obesity and insulin resistance) result in β-cell compensation in cell number and insulin secretion. In order to test whether IGF-I could promote islet cell growth and facilitate islet compensation due to obesity-induced insulin resistance, we have challenged MT-IGF mice to a high-fat diet. After 28 weeks, both MT-IGF mice and wild-type littermates gained comparable 40–57% of body weight, with similar increases in fat masses; all mice maintained a normal sensitivity to insulin and did not become severely hyperglycemic. Nevertheless, compared to wild-type littermates, the equally obese MT-IGF mice maintained improved glucose tolerance and a diminished insulin level; similar to when fed a normal chow diet. More importantly, under IGF-I overexpression, there was no further increase in β-cell mass caused by obesity. Thus, IGF-I overexpression had no significant effect on weight gain and islet cell compensation in response to high-fat diet-induced obesity.
Similar content being viewed by others
References
D. LeRoith, Insulin-like growth factors. N. Engl. J. Med. 336, 633–640 (1997)
J.P. Liu, J. Baker, A.S. Perkins, E.J. Robertson, A. Efstratiadis, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59–72 (1993)
L. Powell-Braxton, P. Hollingshead, C. Warburton et al., IGF-I is required for normal embryonic growth in mice. Genes Dev. 7, 2609–2617 (1993)
J.L. Liu, D. LeRoith, Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140, 5178–5184 (1999)
A. Rabinovitch, C. Quigley, T. Russell, Y. Patel, D.H. Mintz, Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate Islet beta-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes 31, 160–164 (1982)
S.R. Hugl, M.F. White, C.J. Rhodes, Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J. Biol. Chem. 273, 17771–17779 (1998)
M. George, E. Ayuso, A. Casellas, C. Costa, J.C. Devedjian, F. Bosch, Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J. Clin. Invest. 109, 1153–1163 (2002)
R.N. Kulkarni, M. Holzenberger, D.Q. Shih et al., Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet. 31, 111–115 (2002)
S. Xuan, T. Kitamura, J. Nakae et al., Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J. Clin. Invest. 110, 1011–1019 (2002)
J.L. Liu, Does IGF-I stimulate pancreatic islet cell growth? Cell. Biochem. Biophy. 48, 115–125 (2007)
R. Yu, S. Yakar, Y.L. Liu et al., Liver-specific IGF-I gene deficient mice exhibit accelerated diabetes in response to streptozotocin, associated with early onset of insulin resistance. Mol. Cell. Endocrinol. 204, 31–42 (2003)
Y. Lu, P.L. Herrera, Y. Guo et al., Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 53, 3131–3141 (2004)
K. Robertson, Y. Lu, K. De Jesus et al., A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Am. J. Physiol. Endocrinol. Metab. 294, E928–E938 (2008)
J. Nielsen, E. Galsgaard, A. Moldrup et al., Regulation of beta-cell mass by hormones and growth factors. Diabetes 50, S25–S29 (2001)
M. Johansson, G. Mattsson, A. Andersson, L. Jansson, P.O. Carlsson, Islet endothelial cells and pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology 147, 2315–2324 (2006)
J.H. Nielsen, S. Linde, B.S. Welinder, N. Billestrup, O.D. Madsen, Growth hormone is a growth factor for the differentiated pancreatic beta-cell. Mol. Endocrinol. 3, 165–173 (1989)
C. Huang, F. Snider, J.C. Cross, Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 150, 1618–1626 (2009)
R.L. Sorenson, T.C. Brelje, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm. Metab. Res. (Hormon- und Stoffwechselforschung) 29, 301–307 (1997)
K. Robertson, J.J. Kopchick, J.L. Liu, Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. Am. J. Physiol. Endocrinol. Metab. 291, E491–E498 (2006)
K. Ohneda, M.H. Ulshen, C.R. Fuller, A.J. D’Ercole, P.K. Lund, Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112, 444–454 (1997)
P. Ye, J. Carson, A.J. D’Ercole, In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15, 7344–7356 (1995)
J.L. Liu, K.T. Coschigano, K. Robertson et al., Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. 287, E405–E413 (2004)
L.S. Mathews, R.E. Hammer, R.R. Behringer et al., Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123, 2827–2833 (1988)
K. De Jesus, X. Wang, J.L. Liu, A general IGF-I overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout. Growth Factors (2009) (in press)
T. Okada, C.W. Liew, J. Hu, et al., Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc. Natl Acad. Sci. USA 104, 8977–8982 (2007)
F.M. Gregoire, C.M. Smas, H.S. Sul, Understanding adipocyte differentiation. Physiol. Rev. 78, 783–809 (1998)
D.B. Hausman, M. DiGirolamo, T.J. Bartness, G.J. Hausman, R.J. Martin, The biology of white adipocyte proliferation. Obes. Rev. 2, 239–254 (2001)
J. Nougues, Y. Reyne, B. Barenton, T. Chery, V. Garandel, J. Soriano, Differentiation of adipocyte precursors in a serum-free medium is influenced by glucocorticoids and endogenously produced insulin-like growth factor-I. Int. J. Obes. Relat. Metab. Disord. 17, 159–167 (1993)
T.G. Ramsay, M.E. White, C.K. Wolverton, Insulin-like growth factor 1 induction of differentiation of porcine preadipocytes. J. Anim. Sci. 67, 2452–2459 (1989)
W. Schmidt, G. Poll-Jordan, G. Loffler, Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP. J. Biol. Chem. 265, 15489–15495 (1990)
P.J. Smith, L.S. Wise, R. Berkowitz, C. Wan, C.S. Rubin, Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3–L1 adipocytes. J. Biol. Chem. 263, 9402–9408 (1988)
A. Lukanova, S. Soderberg, P. Stattin et al., Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 13, 509–516 (2002)
A. Doglio, C. Dani, G. Fredrikson, P. Grimaldi, G. Ailhaud, Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation. EMBO J. 6, 4011–4016 (1987)
K. Sjogren, K. Wallenius, J.L. Liu et al., Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50, 1539–1545 (2001)
M. Scacchi, A.I. Pincelli, F. Cavagnini, Growth hormone in obesity. Int. J. Obes. Relat. Metab. Disord. 23, 260–271 (1999)
Y. Guo, Y. Lu, D. Houle et al., Pancreatic islet-specific expression of an IGF-I transgene compensates islet cell growth in growth hormone receptor gene deficient mice. Endocrinology 146, 2602–2609 (2005)
M.S. Islam, T. Loots du, Diabetes, metallothionein, and zinc interactions: a review. Biofactors 29, 203–212 (2007)
Acknowledgment
This work was supported by funding from Canadian Institutes of Health Research (MOP-84389), National Science and Engineering Research Council of Canada (341205-07), and Qingdao Municipal of Science and Technology Commission (NO. 07-2-1-4-nsh), Shandong, China. Scholarship support to JLL was provided by JR & CM Fraser Memorial Fund and Fonds de la recherché en santé Quebec. KR received studentship support from MUHC Research Institute. MT-IGF mice were provided by Dr. J. D’Ercole of University of North Carolina.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robertson, K., Dong, J., De Jesus, K. et al. IGF-I overexpression does not promote compensatory islet cell growth in diet-induced obesity. Endocr 37, 47–54 (2010). https://doi.org/10.1007/s12020-009-9259-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9259-y